These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2802259)

  • 1. Attenuation of the vasoconstrictor action of neuropeptide-Y by calcium-channel blockers.
    Aizawa Y; Niwano S; Aizawa M; Tamura M; Shibata A
    Angiology; 1989 Oct; 40(10):890-4. PubMed ID: 2802259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
    Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A
    Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
    Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
    Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs.
    Hayashi M; Aizawa Y; Satoh M; Suzuki K; Shibata A
    Jpn Heart J; 1986 Mar; 27(2):251-7. PubMed ID: 3755186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.
    Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE
    J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained coronary constriction and its antagonism by calcium-blocking agents in monkeys and baboons.
    Taira N; Satoh K; Maruyama M; Yamashita S
    Circ Res; 1983 Feb; 52(2 Pt 2):I40-6. PubMed ID: 6403259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers.
    Martin SE; Patterson RE
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H927-34. PubMed ID: 2506768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
    Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
    Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J
    Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2.
    Martin SE; Kuvin JT; Offenbacher S; Odle BM; Patterson RE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):H1045-53. PubMed ID: 1415751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity and dissimilarity of the vasoconstrictor effects of Bay K 8644 on coronary, femoral, mesenteric and renal circulations of dogs.
    Ishii K; Sato Y; Taira N
    Br J Pharmacol; 1986 Jun; 88(2):369-77. PubMed ID: 2425879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of endothelin as a coronary vasoconstrictor in the Langendorff-perfused rat heart.
    Fukuda K; Hori S; Kusuhara M; Satoh T; Kyotani S; Handa S; Nakamura Y; Oono H; Yamaguchi K
    Eur J Pharmacol; 1989 Jun; 165(2-3):301-4. PubMed ID: 2673800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcium channel blockers on coronary vasoconstriction induced by endothelin-1 in closed chest pigs.
    Egashira K; Pipers FS; Rush JE; Morgan JP
    J Am Coll Cardiol; 1990 Nov; 16(5):1296-303. PubMed ID: 2229778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm?
    Igarashi Y; Aizawa Y; Tamura M; Ebe K; Yamaguchi T; Shibata A
    Am Heart J; 1989 Oct; 118(4):674-8. PubMed ID: 2679015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmural regulation of myocardial perfusion by neuropeptide Y.
    Gutterman DD; Morgan DA
    Basic Res Cardiol; 1995; 90(4):348-55. PubMed ID: 8534260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nisoldipine on coronary collateral perfusion and hemodynamics in chronically instrumented dogs.
    Kenny D; Hartman JC; Brooks HL; Warltier DC
    Pharmacology; 1989; 38(4):263-71. PubMed ID: 2755966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neuropeptide Y on regulation of blood flow rate in canine myocardium.
    Svendsen JH; Sheikh SP; Jørgensen J; Mikkelsen JD; Paaske WP; Sejrsen P; Haunsø S
    Am J Physiol; 1990 Dec; 259(6 Pt 2):H1709-17. PubMed ID: 2260698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nisoldipine on coronary resistance, contractility and oxygen consumption of the isolated blood-perfused canine left ventricle.
    Schipke JD; Burkhoff D; Alexander J; Schaefer J; Sagawa K
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1000-4. PubMed ID: 3252017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
    Takahashi K; Taira N
    Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.